Oncology PracticePhase 3 study confirms biosimilarity of PF-05280586 with rituximabDecember 5, 2018Lymphoma & Plasma Cell DisordersAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology NewsCLL resistance mechanism to venetoclax identifiedDecember 5, 2018CLLAggressive LymphomasLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsIn IDH-mutated AML, first-line IDH inhibitors plus chemo may boost remissionDecember 5, 2018AMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsShorter R-CHOP regimen noninferior in certain DLBCL patientsDecember 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesRegimen provides survival benefit in PTCLDecember 4, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaB Cell Lymphoma
Hematology TimesUpdate shows durable responses in rel/ref DLBCLDecember 4, 2018Lymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsTOURMALINE-MM3: Ixazomib improves PFS after myeloma transplantDecember 2, 2018Multiple MyelomaLymphoma & Plasma Cell DisordersCellular Therapy
Hematology NewsJULIET: CAR T cells go the distance in r/r DLBCLDecember 2, 2018Aggressive LymphomasCellular TherapyLymphoma & Plasma Cell DisordersImmuno-oncologyB Cell Lymphoma
Hematology NewsBeat AML trial delivers genomic results in 7 daysDecember 2, 2018AMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsJULIET: CAR T cells keep trucking against DLBCLDecember 2, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesNew PCNSL guidelines emphasize importance of patient fitnessDecember 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsFLYER: Four cycles of R-CHOP as good as six in low-risk DLBCLDecember 1, 2018Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsFLYER: R-CHOP 4 safer, as effective for low-risk DLBCL patients under 60December 1, 2018Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsNew data further support curability of myelomaNovember 29, 2018Multiple MyelomaLymphoma & Plasma Cell DisordersCellular Therapy
Hematology TimesFDA approves biosimilar rituximab for NHLNovember 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
